Your browser doesn't support javascript.
loading
Optimal interval of endoscopic screening based on stage distributions of detected gastric cancers.
Hamashima, Chisato; Narisawa, Rintaro; Ogoshi, Kazuei; Kato, Toshiyuki; Fujita, Kazutaka.
Afiliación
  • Hamashima C; Division of Cancer Screening Assessment and Management, Center for Public Health Science, National Cancer Center, 5-1-1 Tsukiji Chuo-ku, Tokyo, 104-0045, Japan. chamashi@ncc.go.jp.
  • Narisawa R; Division of Gastroenterology, Niigata Cancer Center Hospital, 2-15-3 Kawagishi-Cho Chuo-ku, Niigata, 951-8566, Japan.
  • Ogoshi K; Cancer Registry Section, Niigata Cancer Center Hospital, 2-15-3 Kawagishi-Cho Cyuo-ku, Niigata, 951-8566, Japan.
  • Kato T; Committee of Gastrointestinal Cancer Screening, Niigata City Medical Association, 3-3-1 Shichikuyama Chuo-ku, Niigata, 950-0914, Japan.
  • Fujita K; Committee of Gastrointestinal Cancer Screening, Niigata City Medical Association, 3-3-1 Shichikuyama Chuo-ku, Niigata, 950-0914, Japan.
BMC Cancer ; 17(1): 740, 2017 Nov 09.
Article en En | MEDLINE | ID: mdl-29121881
ABSTRACT

BACKGROUND:

Although Korea and Japan have a national gastric cancer screening program, their screening intervals are different. The optimal screening interval of endoscopic screening in Japan was investigated based on the stage distributions of screen-detected gastric cancers.

METHODS:

Patients with gastric cancer detected by endoscopic and radiographic screenings were selected from the Niigata City Medical Association database. The stage distributions of the detected gastric cancers were compared among patients with different screening histories in both groups. Gastric cancer specific survival rates were analyzed using the Kaplan-Meier method with the log-rank test.

RESULTS:

There were 1585 and 462 subjects in the endoscopic and radiographic screening groups, respectively. In the endoscopic screening group, the stage IV proportion was lower in patients with screening history 1 and 2 years before diagnosis than in patients without screening history. Stage IV development was significantly related to the absence of screening history (p < 0.001); however, there were no differences between patients who had endoscopic screening history 2 and 3 years before diagnosis. The survival rates were not significantly different between patients with endoscopic screening 1 and 2 years previously (p = 0.7763). The survival rates were significantly higher in patients with endoscopic screening history 1 and 2 years before diagnosis than in patients without screening history (p < 0.001), and in patients with endoscopic screaming 3 years before diagnosis (P < 0.0069).

CONCLUSION:

The endoscopic screening interval for gastric cancer can be expanded to at least 2 years based on the stage distributions of detected cancers and the patient survival rates.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias Gástricas / Endoscopía Gastrointestinal / Detección Precoz del Cáncer Tipo de estudio: Diagnostic_studies / Screening_studies Límite: Adult / Aged / Female / Humans / Male / Middle aged País/Región como asunto: Asia Idioma: En Revista: BMC Cancer Asunto de la revista: NEOPLASIAS Año: 2017 Tipo del documento: Article País de afiliación: Japón

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias Gástricas / Endoscopía Gastrointestinal / Detección Precoz del Cáncer Tipo de estudio: Diagnostic_studies / Screening_studies Límite: Adult / Aged / Female / Humans / Male / Middle aged País/Región como asunto: Asia Idioma: En Revista: BMC Cancer Asunto de la revista: NEOPLASIAS Año: 2017 Tipo del documento: Article País de afiliación: Japón